Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson's disease: Results through 24 months from a Phase 1 study Meeting Abstract

  

Authors:	Henchcliffe, C.; Sarva, H.; Lozano, A.; Fasano, A.; Kalia, S.; Yu, K. K. H.; Brennan, C.; Floro, N.; Stemple, W.; Abid, N.; Tabar, V.
Abstract Title:	Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson's disease: Results through 24 months from a Phase 1 study
Meeting Title:	30th World Congress on Parkinson's Disease and Related Disorders (2025)
Journal Title:	Parkinsonism & Related Disorders
Volume:	134
Meeting Dates:	2025 May 7-10
Meeting Location:	New York, NY
ISSN:	1353-8020
Publisher:	Elsevier Science, Inc.
Date Published:	2025-05-01
Start Page:	115
End Page:	116
DOI:	10.1016/j.parkreldis.2025.107606
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://research.ebsco.com/linkprocessor/plink?id=52ce39df-5a86-3abd-b400-740275d258ed
Notes:	Meeting abstract: 0127 -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/225973